Platelet Endothelial Cell Adhesion Molecule‐1 Mediates Endothelial‐Cardiomyocyte Communication and Regulates Cardiac Function
Open Access
- 5 January 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 4 (1) , e001210
Abstract
Background: Dilated cardiomyopathy is characterized by impaired contractility of cardiomyocytes, ventricular chamber dilatation, and systolic dysfunction. Although mutations in genes expressed in the cardiomyocyte are the best described causes of reduced contractility, the importance of endothelial‐cardiomyocyte communication for proper cardiac function is increasingly appreciated. In the present study, we investigate the role of the endothelial adhesion molecule platelet endothelial cell adhesion molecule ( PECAM ‐1) in the regulation of cardiac function. Methods and Results: Using cell culture and animal models , we show that PECAM ‐1 expressed in endothelial cells ( EC s) regulates cardiomyocyte contractility and cardiac function via the neuregulin‐ErbB signaling pathway. Conscious echocardiography revealed left ventricular ( LV ) chamber dilation and systolic dysfunction in PECAM ‐1 −/− mice in the absence of histological abnormalities or defects in cardiac capillary density. Despite deficits in global cardiac function, cardiomyocytes isolated from PECAM ‐1 −/− hearts displayed normal baseline and isoproterenol‐stimulated contractility. Mechanistically, absence of PECAM ‐1 resulted in elevated NO / ROS signaling and NRG ‐1 release from EC s, which resulted in augmented phosphorylation of its receptor ErbB2. Treatment of cardiomyocytes with conditioned media from PECAM ‐1 −/− EC s resulted in enhanced ErbB2 activation, which was normalized by pre‐treatment with an NRG ‐1 blocking antibody. To determine whether normalization of increased NRG ‐1 levels could correct cardiac function, PECAM ‐1 −/− mice were treated with the NRG ‐1 blocking antibody. Echocardiography showed that treatment significantly improved cardiac function of PECAM ‐1 −/− mice, as revealed by increased ejection fraction and fractional shortening. Conclusions: We identify a novel role for PECAM ‐1 in regulating cardiac function via a paracrine NRG 1‐ErbB pathway. These data highlight the importance of tightly regulated cellular communication for proper cardiac function.Keywords
This publication has 52 references indexed in Scilit:
- APJ acts as a dual receptor in cardiac hypertrophyNature, 2012
- Hyperphosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 Is Not Involved in Cardiac Dysfunction After Myocardial InfarctionCirculation Research, 2012
- RETRACTED: Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signalingProceedings of the National Academy of Sciences, 2012
- Neuregulin-1β for the treatment of systolic heart failureJournal of Molecular and Cellular Cardiology, 2011
- Platelet-Endothelial Cell Adhesion Molecule-1 Regulates Endothelial NO Synthase Activity and Localization Through Signal Transducers and Activators of Transcription 3–Dependent NOSTRIN ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Role of PECAM-1 in Arteriogenesis and Specification of Preexisting CollateralsCirculation Research, 2010
- PECAM-1 Is Necessary for Flow-Induced Vascular RemodelingArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Measurement of cardiac function using pressure–volume conductance catheter technique in mice and ratsNature Protocols, 2008
- Minimal regulation of platelet activity by PECAM-1Platelets, 2007
- Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failureGenes & Development, 2006